Exploring the Role of Histone Lysine Methyl Transferases in Pancreatic Cancer: A Review of Therapeutics and Clinical Implications

Histone Lysine Methyl Transferases (HKMTs) are pivotal epigenetic regulators that modulate chromatin structure and gene expression, thereby influencing various cellular processes, and their molecular mechanisms and functional significance in health and disease are being elucidated. We discuss the involvement of HKMTs in a number of diseases, including cancer, neurodegenerative disorders, and metabolic diseases, and emphasise the importance of their conserved regions and interactions with histone substrates. In addition, we explore the therapeutic potential of HKMT inhibitors in the treatment of these diseases, highlighting their promising efficacy and potential advantages over conventional therapies. Despite the encouraging clinical outcomes, it remains difficult to understand the specificity and long-term consequences of HKMT inhibition, so further research and clinical evaluation are required. This review provides valuable insights into the complex regulatory role of HKMTs in epigenetic processes and offers perspectives for the development of novel therapeutic strategies with clinical implications for pancreatic cancer.

View article page

Download PDF